Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DXM Panel Proposes Augmenting, Improving Education To Curb Abuse

This article was originally published in The Tan Sheet

Executive Summary

Members of an FDA panel tipped their hats to the Consumer Healthcare Product Association's efforts to reduce dextromethorphan abuse, but floated enhancements to the program

You may also be interested in...



Consumer OTC Ingredient Survey Reveals Need For Education

A CHPA-funded survey found one-third of consumers do not understand what common OTC ingredients do – putting them at risk for using the wrong drug or overdosing. The trade group and firms can educate these consumers through a stronger online presence, by working with providers and giving necessary information to key influencers.

Consumer OTC Ingredient Survey Reveals Need For Education

A CHPA-funded survey found one-third of consumers do not understand what common OTC ingredients do – putting them at risk for using the wrong drug or overdosing. The trade group and firms can educate these consumers through a stronger online presence, by working with providers and giving necessary information to key influencers.

Cough Drug Abuse By Teens Drops, But Persists Among Younger Children

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104510

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel